Royalty Pharma plc - Class A — Cash Flow (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 2.03 B2.02 B2.14 B2.99 B2.77 B2.49 B 2.49 B Cash from investing activities 2.76 B1.87 B1.03 B2.07 B2.68 B1.61 B 1.61 B Cash from financing activities 1.49 B385.11 M944.86 M2.15 B361.14 M1.19 B 1.19 B Free cash flow 2.03 B2.02 B2.14 B2.99 B2.77 B2.49 B 2.49 B

新闻

TD Cowen上调Royalty Pharma目标价至50美元,看好增长前景

TD Cowen raises Royalty Pharma stock price target to $50 on growth

Royalty Pharma股价触及52周高点46.14美元

Royalty Pharma stock hits 52-week high at 46.14 USD

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

美银证券重申Royalty Pharma股票买入评级，目标价54美元

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

Royalty Pharma股价触及52周高点44.94美元

Royalty Pharma stock hits 52-week high at 44.94 USD

Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion